• Tirzepatide, a novel once-weekly GIP and GLP-1 receptor agonist, is approved by FDA for the treatment of adults with type 2 diabetes2.TZP demonstrated significant weight reduction in …
Improving Adherence & Persistence in HR+,HER2- Breast Cancer
Join Dr. Shaheenah Dawood, a renowned oncologist, as she provides valuable advice and strategies for oncology health care professionals to improve adherence and persistence in …
Jun 21, 2022 · A Look Into the Role of IL-13 in the Immunopathogenesis of AD
Cuida tu corazón Para las personas hispanas y latinoamericanas ersonas que viven en los Estados Unidos. Tener diabetes podría aumentar tus posibilidades de padecer una …
Eczchanges: Talking About Atopic Dermatitis provides healthcare practitioners and patients with the resources they need to start these challenging conversations.